During the past decade, Infirmary Cancer Care conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Infirmary Cancer Care" #1 collaborator was "Cancer Commons" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Infirmary Cancer Care" are "BRAF Gene Mutation" (1 trials), "Bladder Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Cholangiocarcinoma" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Infirmary Cancer Care" in a lesser frequency.

Most popular intervention types in "Infirmary Cancer Care" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Exemestane" (1 trials), "Gemcitabine" (1 trials), "Imlunestrant" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infirmary Cancer Care" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Infirmary Cancer Care". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Infirmary Cancer Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Infirmary Cancer Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".